Request a Proposal
Welcome to Rapport, containing tips, truths, news and views, blogs, tweets, articles and films covering a range of topics currently affecting Research Partnership and the pharma market research world.

How a combined qual quant approach provided our client with integral insights for continued product development in the HIV space

How a combined qual quant approach provided our client with integral insights for continued product development in the HIV space

Our client was looking to develop novel HIV prevention products, and wanted to explore different formulation options.

They wanted to learn both the reactions to the novel formulations as well as the impact of out-of-pocket (OOP) costs. Research was required to explore physician and consumer interest and gauge the impact of these developments on new and existing products. 

read more »

  • Posted by Mariel Metcalfe
  • July 11, 2019
  • News

Research Partnership launches new patient Living with Psoriatic Arthritis (PsA) 2019 EU report

Research Partnership launches new patient Living with Psoriatic Arthritis (PsA) 2019 EU report

Living with Psoriatic Arthritis is new a report conducted amongst 265 patients in France, Germany, Italy, Spain and UK. The report is based on the findings from 30-minute quantitative online and qualitative telephone interviews with patients. It will provide an update on the existing Living with PsA report published in 2016 and will be available to purchase in October 2019.

read more »

  • Posted by Sue Rees
  • July 10, 2019
  • Articles

New hopes for Mexico

New hopes for Mexico

What will be the future of healthcare under the country's new administration?

In December 2018 the new Mexican President, Andres Manuel Lopez Obrador came into office after a landslide victory of over 65% of the votes (more than 30 billion voters). López Obrador was a former Mexico City mayor and has been a major political figure for over twenty years. Widely regarded as both a populist and nationalist, his ideology is to end poverty and improve the lives of his people by fighting corruption and increasing austerity within the government. 

read more »

  • Posted by Julie Denny
  • July 5, 2019
  • News

London employees enjoy annual summer day out

London employees enjoy annual summer day out

This year’s summer day out was not for the faint-hearted. Our London team bravely participated in tree-climbing and other activities at Go Ape in Battersea Park.

Each team was assigned a name based on a tree-climbing animal and asked to dress in a manner appropriate to their team name. Half the teams went up into the trees in the morning, and the second half took part in team development games in the park. The games included minefield, plank walk and the blindfolded knot. There was also mini golf for those who weren’t keen on heights.
 

read more »

  • Posted by Rachel Arthurs
  • July 1, 2019
  • Blogs

Living with rheumatoid arthritis: How social stigma, unemployment and the rise of mental illness affects patient attitudes toward their disease in Japan

Living with rheumatoid arthritis: How social stigma, unemployment and  the rise of mental illness affects patient attitudes toward  their disease in Japan

Rachel Arthurs explores differing social attitudes towards RA between patients living in Japan and patients in Europe and Canada.

In recent months, Research Partnership’s Mariel Metcalfe alongside her Living With team have been conducting an in-depth multi-country study into the experiences of those living with rheumatoid arthritis. The study was carried out amongst patients in Europe, Canada and Japan to gain insights into the ways in which patients react to their diagnosis, manage their treatment and the possible support they hope to see in the future. An interesting trend that emerged during the course of the research was the differing social attitudes towards illness between patients living in Japan compared to those in Europe and Canada. Japanese patient’s daily lives are impacted differently to those in other countries, possibly due to pre-existing stigmas and social attitudes. In this article, we examine these differences, consider why they might occur and propose how we can use this understanding to improve global treatment solutions and marketing of existing and pipeline pharmaceuticals.

read more »